Nine‐ to fourteen‐year follow‐up of implant treatment. Part II: presence of peri‐implant lesions

TLDR

The study aimed to determine the prevalence of peri‑implant lesions after 9–14 years of implant function. A cohort of 294 patients with 999 implants, treated between 1988–1992, was recalled and examined clinically and radiographically 10–14 years after placement. At 10–14 years, 48 % of implants showed mucositis, 20.4 % had bone loss ≥3.1 mm, 7.7 % exhibited progressive bone loss, and peri‑implantitis was present in 16 % of patients (6.6 % of implants).

Abstract

Abstract Objectives: The aim of this study was to analyse the proportions of peri‐implant lesions at implants after 9–14 years of function. Material and Methods: Two hundred and ninety‐four patients underwent implant therapy during the years 1988–1992 in Kristianstad County. These individuals were recalled to the speciality clinic 1 and 5 years after placement of the suprastructure. Between 2000 and 2002, 218 patients with 999 implants were examined clinically and radiographically. Results: Forty‐eight per cent of the implants had probing depth 4 mm and bleeding on probing (peri‐implant mucositis). In 20.4% of the implants, the bone level was located 3.1 mm apical to the implant shoulder. Progressive bone loss (1.8 mm) during the observation period was found in 7.7% of the implants. Peri‐implantitis defined as bone loss 1.8 mm compared with 1‐year data (the apical border of the bony defect located at or apical to the third thread, i.e. a minimum of 3.1 mm apical to the implant shoulder), combined with bleeding on probing and or pus, were diagnosed among 16% of the patients and 6.6% of the implants. Conclusion: After 10 years in use without systematic supportive treatment, peri‐implant lesions is a common clinical entity adjacent to titanium implants.